PL2201120T3 - Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów - Google Patents

Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów

Info

Publication number: PL2201120T3
Authority: PL; Poland
Prior art keywords: peptides; fusion protein; high expression; systems suitable; protein systems
Prior art date: 2007-09-21

Application number

PL08852235T

Other languages

English (en)

Inventor

Sanjeev Kumar Mendiretta

Pankaj R Patel

Sanjay Bandyopadhyay

Vibhor Saraswat

Arun Kumar Singh

Original Assignee

Cadila Healthcare Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-21

Filing date

2008-09-22

Publication date

2014-05-30

2008-09-22 Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd

2014-05-30 Publication of PL2201120T3 publication Critical patent/PL2201120T3/pl

Links

108020001507 fusion proteins Proteins 0.000 title 1
102000037865 fusion proteins Human genes 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Biotechnology (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)

PL08852235T 2007-09-21 2008-09-22 Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów PL2201120T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN1848MU2007		2007-09-21
EP08852235.4A EP2201120B1 (en)	2007-09-21	2008-09-22	Gcsf fusion protein systems suitable for high expression of peptides
PCT/IN2008/000599 WO2009066320A2 (en)	2007-09-21	2008-09-22	Fusion protein systems suitable for high expression of peptides

Publications (1)

Publication Number	Publication Date
PL2201120T3 true PL2201120T3 (pl)	2014-05-30

Family

ID=40667943

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08852235T PL2201120T3 (pl)	2007-09-21	2008-09-22	Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów

Country Status (7)

Country	Link
US (1)	US8507221B2 (pl)
EP (2)	EP2201120B1 (pl)
JP (1)	JP5368450B2 (pl)
AU (1)	AU2008327513B2 (pl)
DK (1)	DK2201120T3 (pl)
PL (1)	PL2201120T3 (pl)
WO (1)	WO2009066320A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102762739A (zh) *	2009-11-09	2012-10-31	科罗拉多州立大学董事会（法人团体）	肽的高效生产
US20200009266A1 (en) *	2017-02-15	2020-01-09	Fred Hutchinson Cancer Research Center	In vivo gene therapy for immune deficiencies
CN106967663B (zh) *	2017-05-06	2020-08-14	中国海洋大学	一种用于农作物病害防治的重组菌株
ES3041991T3 (en)	2017-05-25	2025-11-17	Leidos Inc	Pd-1 and ctla-4 dual inhibitor peptides
JP2021509805A (ja) *	2017-12-27	2021-04-08	カウンシルオブサイエンティフィックアンドインダストリアルリサーチ	顆粒球コロニー刺激因子活性を示すポリペプチド
US11267863B2 (en)	2018-01-19	2022-03-08	Pepgene Inc.	N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
JP7606471B2 (ja)	2019-05-22	2024-12-25	レイドス，インコーポレイテッド	Ｌａｇ３結合ペプチド
RU2728611C1 (ru) *	2019-05-24	2020-07-30	Закрытое акционерное общество "ФАРМ-ХОЛДИНГ"	РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pF265, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД, СОДЕРЖАЩИЙ ПРОИНСУЛИН ЧЕЛОВЕКА, И ШТАММ БАКТЕРИЙ Escherichia coli - ПРОДУЦЕНТ ГИБРИДНОГО ПОЛИПЕПТИДА, СОДЕРЖАЩЕГО ПРОИНСУЛИН ЧЕЛОВЕКА
EP4188947A2 (en)	2020-07-31	2023-06-07	Leidos, Inc.	Lag3 binding peptides
CN116731126B (zh) *	2023-01-30	2024-02-23	态创生物科技(广州)有限公司	内含肽ChiATP、内含肽ChiATP-二肽-2融合蛋白及二肽-2的表达方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ199391A (en)	1981-01-02	1985-12-13	Genentech Inc	Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3526995A1 (de)	1985-07-27	1987-02-05	Hoechst Ag	Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung
US5223404A (en)	1988-01-20	1993-06-29	Sunstar Kabushiki Kaisha	Composition for testing periodontal diseases
JP3531947B2 (ja)	1991-08-19	2004-05-31	第一サントリーファーマ株式会社	ペプチドの製造方法
US5738849A (en) *	1992-11-24	1998-04-14	G. D. Searle & Co.	Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
KR100230578B1 (ko)	1997-07-25	1999-12-01	허영섭	포스포리불로키나제를 융합파트너로 이용하는 재조합 인간 부갑상선호르몬의 발현벡터
EP1981546B1 (en) *	2006-02-06	2014-06-04	The Medical Research and Infrastructure Fund of the Tel-Aviv Sourasky Medical Center	Enzyme replacement therapy for treating lysosomal storage diseases
WO2007102174A2 (en)	2006-03-06	2007-09-13	Cadila Healthcare Limited	Process for preparing human g-csf

2008
- 2008-09-22 PL PL08852235T patent/PL2201120T3/pl unknown
- 2008-09-22 JP JP2010525497A patent/JP5368450B2/ja not_active Expired - Fee Related
- 2008-09-22 EP EP08852235.4A patent/EP2201120B1/en active Active
- 2008-09-22 DK DK08852235.4T patent/DK2201120T3/en active
- 2008-09-22 US US12/679,346 patent/US8507221B2/en not_active Expired - Fee Related
- 2008-09-22 EP EP12179359.0A patent/EP2522728A1/en not_active Withdrawn
- 2008-09-22 WO PCT/IN2008/000599 patent/WO2009066320A2/en not_active Ceased
- 2008-09-22 AU AU2008327513A patent/AU2008327513B2/en not_active Ceased

Also Published As

Publication number	Publication date
JP2010539898A (ja)	2010-12-24
AU2008327513A2 (en)	2010-06-17
DK2201120T3 (en)	2014-03-17
JP5368450B2 (ja)	2013-12-18
WO2009066320A2 (en)	2009-05-28
EP2201120B1 (en)	2013-12-25
EP2522728A1 (en)	2012-11-14
EP2201120A2 (en)	2010-06-30
US20120142891A1 (en)	2012-06-07
WO2009066320A3 (en)	2009-09-24
AU2008327513B2 (en)	2012-05-03
AU2008327513A1 (en)	2009-05-28
US8507221B2 (en)	2013-08-13

Publication	Publication Date	Title
PL2201120T3 (pl)	2014-05-30	Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
IL275846A (en)	2020-08-31	ACTRIIB–FC truncated fusion proteins
IL202128A0 (en)	2010-06-16	Immunoglobulin fusion proteins
IL210175A0 (en)	2011-03-31	Fn14/trail fusion proteins
IL196889A0 (en)	2011-08-01	Albumin-insulin fusion proteins
IL204839A0 (en)	2010-11-30	Albumin fusion proteins
IL206606A0 (en)	2010-12-30	Protein expression systems
IL205716A0 (en)	2010-11-30	Formulations for taci-immunoglobulin fusion proteins
EP2161287A4 (en)	2010-08-11	OPTIMIZED TACI FC FUSION PROTEINS
IL219313A (en)	2017-03-30	Proximity-mediated assays for detecting oncogenic fusion proteins
EP2413969A4 (en)	2012-09-05	FUSION PROTEINS WITH DOG FC ELEMENTS
IL222924A0 (en)	2012-12-31	Albumin fusion proteins
IL197580A0 (en)	2011-08-01	Albumin fusion proteins
IL205107A0 (en)	2010-11-30	Method for purifying fc-fusion proteins
IL215005A0 (en)	2011-11-30	Ox40/trail fusion proteins
PL2144924T3 (pl)	2017-06-30	Szczepionka z białkiem fuzyjnym
IL202225A0 (en)	2010-06-16	Growth hormone fusion proteins
GB2465683B (en)	2012-01-18	LL-37 Related Fusion Peptides
IL204949A0 (en)	2010-11-30	Method for purifying an fc- containing protein
PL2622078T3 (pl)	2015-05-29	Białko fuzyjne dla ekspresji białka wydzielniczego
GB0725201D0 (en)	2008-01-30	Peptide fusion proteins
IL205718A0 (en)	2010-11-30	Taci-immunoglobulin fusion proteins for treatment of relapsing multiple sclerosis
GB0700759D0 (en)	2007-02-21	Novel fusion protein
GB0715325D0 (en)	2007-09-19	Fertilisation protein
GB0713169D0 (en)	2007-08-15	Fusion proteins